Covax, says Masiyiwa, is culpable of the failure. “We were misled. […] We got to December believing the whole world was coming together to purchase vaccines, not knowing that we had been corralled into a little corner, whilst others ran off and secured supplies. That’s what Covax was supposed to do for us,” he said. Masiyiwa says Covax’s decision to procure vaccines primarily from the Serum Institute of India was fraught because the risks attached with sourcing from just one facility were too high.

📬 Sign up for the Daily Brief

Our free, fast, and fun briefing on the global economy, delivered every weekday morning.